NCT03389100
Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
Enrolling by Invitation
PHASE2Ages 55–69InterventionalDiagnosticColumbia UniversityInvestigator-initiated
~600 participants
Updated 2025-05-06 on ClinicalTrials.gov
What's tested:18F-MK6240 injection
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
18F-MK6240 standardized update value ratio (SUVR)
Measured over 18 to 30 months
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Jose A. Luchsinger, MD · PRINCIPAL_INVESTIGATOR · Columbia University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- 18F-MK6240 standardized update value ratio (SUVR)18 to 30 months
The primary outcome measure will be regional standardized uptake value ratio (SUVR) values for 18F-MK-6240 using cerebellum as reference region. Kinetic modeling using Logan DVR method may also be employed. Multiple brain regions will be measured, with particular attention to medial temporal cortex structures such as hippocampus and entorhinal cortex